ASSET | DATE | % RETURN |
---|---|---|
Nutex Health (NUTX) | 8/1/2014 - 4/1/2015 | 1,438.46% |
Andretti Acquisition Corp II Class A Ordinary Shares (POLE) | 8/1/2014 - 4/1/2015 | 896.73% |
CorMedix (CRMD) | 8/1/2014 - 4/1/2015 | 398.48% |
Ocular Therapeutix (OCUL) | 8/1/2014 - 4/1/2015 | 217.71% |
Covenant Logistics (CVLG) | 8/1/2014 - 4/1/2015 | 179.83% |
Regulus Therapeutics (RGLS) | 8/1/2014 - 4/1/2015 | 176.55% |
Kimball Electronics (KE) | 8/1/2014 - 4/1/2015 | 175.14% |
Allient (ALNT) | 8/1/2014 - 4/1/2015 | 171.63% |
Amicus Therapeutics (FOLD) | 8/1/2014 - 4/1/2015 | 162.29% |
Frp Holdings Ord (FRPH) | 8/1/2014 - 4/1/2015 | 161.09% |
TSS, Inc Common Stock (TSSI) | 8/1/2014 - 4/1/2015 | 158.33% |
ANI Pharmaceuticals (ANIP) | 8/1/2014 - 4/1/2015 | 151.02% |
Agios Pharm (AGIO) | 8/1/2014 - 4/1/2015 | 137.91% |
Uniqure (QURE) | 8/1/2014 - 4/1/2015 | 130.28% |
1-800 FLOWERS (FLWS) | 8/1/2014 - 4/1/2015 | 128.79% |
Universal Insurance (UVE) | 8/1/2014 - 4/1/2015 | 125.21% |
Travere Therapeutics (TVTX) | 8/1/2014 - 4/1/2015 | 121.9% |
Lendingtree (TREE) | 8/1/2014 - 4/1/2015 | 119.1% |
Capricor Therapeutics (CAPR) | 8/1/2014 - 4/1/2015 | 118.99% |
Ingles Markets (IMKTA) | 8/1/2014 - 4/1/2015 | 111.41% |
Celldex Therapeutics (CLDX) | 8/1/2014 - 4/1/2015 | 106.68% |
Precigen (PGEN) | 8/1/2014 - 4/1/2015 | 96.73% |
Novavax (NVAX) | 8/1/2014 - 4/1/2015 | 91.69% |
Build-A-Bear Workshop (BBW) | 8/1/2014 - 4/1/2015 | 89.93% |
Phibro Animal Health (PAHC) | 8/1/2014 - 4/1/2015 | 89.77% |